29
Total investments
15
Early stage
7
Mid stage
1
Late stage
6y
Years active
Portfolio
27 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
May 2026
Haddy is a 3D digital manufacturer serving retailers and commercial developers with all furniture needs. Our products are sustainable, designed, beautiful, and on time. We operate the worlds first regional, commercial-level microfactories, enabling local, on-demand production.
Investor
Jan 2025
Atlas Data Storage is pioneering the use of DNA as a highly durable, low cost permanent data storage medium.
Investor
Jul 2024
Dosu makes engineering knowledge accessible to everyone. Like an engineering teammate, Dosu uses its understanding of code and code changes to answer undocumented questions from sales, triage customer-facing bugs with support, collaborate on release notes with product, and more.
Investor
Sep 2023
Machina Labs unlocks manufacturing with AI & Robotics. Machinas Robotic Craftsman is introducing unseen flexibility and agility to the centuries-old manufacturing industry, enabling rapid iteration and innovation to design, engineering, and production. Machina helps leading companies quickly and affordably turn great ideas into reality.
Investor
Jun 2023
SkyFi is an Earth intelligence company delivering satellite imagery, SAR, AIS, and AI-driven geospatial analytics through scalable data platforms. Headquartered in Austin, Texas, we serve the U.S. Government, international governments, and enterprise customers across defense, civil, and commercial sectors.
Our platform streamlines on-demand access to geospatial data by combining tasking, archive search, and analytics into a single platform. With transparent pricing and rapid delivery, SkyFi helps organizations gain timely intelligence for missions and initiatives.
Investor
Feb 2023
Pushing the performance of generative AI to the very limits of what’s physically possible.
Investor
Nov 2022
Vaccine Company, a wholly owned subsidiary of Eli Lilly and Company, was founded to bring next-generation antigen engineering to vaccine science. Our proprietary In Vivo Nanoparticle (IVN) technologies are designed to combine the strengths of mRNA and virus-like particle approaches to enable durable, multivalent immune responses to challenging viral targets. We are advancing a pipeline of preclinical and IND-enabling programs, led by a vaccine candidate for the prevention of infectious mononucleosis caused by Epstein-Barr virus.
Investor
Sep 2022
Rippl is transforming dementia care through a pioneering new care model that expands access to specialized dementia care, personalized and proactive care plans, and innovative technology. In coordination with the Alzheimers Association, Rippl provides 24/7 support and personalized care when and where its needed.
Rippl can take full risk on total cost of care for all members with dementia in a given geography, and partners with value-based organizations to optimize patient outcomes and financial performance.
Founded by a group of impatient optimists and doers from the country’s most iconic health care and consumer brands (who have all been caregivers themselves), and backed by visionary venture investors ARCH Venture Partners, General Catalyst, GV, F-Prime Capital, Mass General Brigham, Kin Ventures, and JSL Health, Rippl is ready to take this urgent challenge head on.
Investor
Aug 2022
Orbital Therapeutics is advancing a new generation of RNA medicines designed to reprogram cells in vivo, treating diseases at their source. This approach offers patients a simpler, safer, and more accessible alternative to today’s complex treatments. Built from day one with a fully integrated platform spanning circular and linear RNA, targeted delivery, and AI-guided design, Orbital is working to develop durable, programmable therapies tailored to the distinct biology of each disease. The company’s lead program, OTX-201, targets autoimmune disease through B cell depletion to reset the immune system. Orbital’s platform is built for expansion into broader autoimmune indications, oncology, next-generation vaccines, and protein therapeutics. Led by a team with deep expertise in RNA science, clinical development, and commercialization, Orbital is united by a shared commitment to reach more patients, in more places, with fewer barriers. Learn more at www.orbitaltx.com.
Investor
May 2022
Feminism, freedom and family. That’s what we were thinking about when we created Babyation. We create bold solutions at the intersection of healthcare, data and technology. We are thoughtfully improving products for the most intimate areas of the body so that women can live their best life as they work, play, parent, and age.
Investor
Apr 2022
Paradigm Health is rebuilding the clinical research ecosystem by creating a platform that enables equitable access to trials for all patients, while enhancing trial efficiency and reducing the barriers to participation for healthcare providers. Incubated by ARCH Venture Partners and backed by leading healthcare and life sciences investors, Paradigm Health aims to break down barriers across the trial ecosystem through one seamless infrastructure implemented at healthcare provider organizations, bringing potentially life-saving therapies to patients faster.
Show all 27 investments ↓
Experience · 29 entries
All (29)
Investments (29)
Board (2)
2026
Investor
May 2026
Haddy is a 3D digital manufacturer serving retailers and commercial developers with all furniture needs. Our products are sustainable, designed, beautiful, and on time. We operate the worlds first regional, commercial-level microfactories, enabling local, on-demand production.
2025
Investor
Aug 2025
Forterra delivers autonomous mission systems for defense. From self-driving land systems to coordinated swarms of robotic systems; the company builds scalable, robust, mission critical hardware and software platforms that empower its customers to deploy autonomy as a force multiplier, extending reach, survivability, and effectiveness across the battlespace and industrial applications. Forterra is headquartered in Clarksburg, Md., with offices in Washington, D.C., Winter Park, Fl., Ketchum, Id. and Palo Alto, Ca.
Media Contact:
press@forterra.com
Show all 29 entries ↓
Investment activity
2020–2026 · 29 investments
Recent (last 2 years)Earlier
